These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39026664)

  • 1. The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia.
    Zhong F; Zhang X; Wang Z; Li X; Huang B; Kong G; Wang X
    Front Immunol; 2024; 15():1402669. PubMed ID: 39026664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia.
    Zhong FM; Yao FY; Yang YL; Liu J; Li MY; Jiang JY; Zhang N; Xu YM; Li SQ; Cheng Y; Xu S; Huang B; Wang XZ
    Cancer Cell Int; 2023 Apr; 23(1):61. PubMed ID: 37024911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia.
    Zhong F; Yao F; Xu S; Zhang J; Liu J; Wang X
    Front Immunol; 2023; 14():1297886. PubMed ID: 38283355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Identify Ferroptosis-Related Genes as Potential Diagnostic Biomarkers for Gastric Intestinal Metaplasia.
    Li T; Yang Q; Liu Y; Jin Y; Song B; Sun Q; Wei S; Wu J; Li X
    Technol Cancer Res Treat; 2024; 23():15330338241272036. PubMed ID: 39169865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ferroptosis-related molecular clusters and genes for diabetic osteoporosis based on the machine learning.
    Wang X; Meng L; Zhang J; Zhao Z; Zou L; Jia Z; Han X; Zhao L; Song M; Zong J; Wang S; Qu X; Lu M
    Front Endocrinol (Lausanne); 2023; 14():1189513. PubMed ID: 37645416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D; Yang W; Zeng Y; Li W; Wang K; Zhao L; Li J; Ye Y; Guo Q
    Cell Signal; 2021 Aug; 84():110038. PubMed ID: 33984486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Ferroptosis-Related Biomarkers for Diagnosis and Molecular Classification of
    Shi X; Tang L; Ni H; Li M; Wu Y; Xu Y
    J Inflamm Res; 2023; 16():1805-1823. PubMed ID: 37131411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ferroptosis biomarkers and immune infiltration landscapes in atrial fibrillation: A bioinformatics analysis.
    Peng S; Li K; Man Y; Liu P
    Medicine (Baltimore); 2024 Sep; 103(39):e39777. PubMed ID: 39331874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and their correlation with immune infiltration in osteoarthritis using integrative bioinformatics approaches and machine-learning strategies.
    Xia D; Wang J; Yang S; Jiang C; Yao J
    Medicine (Baltimore); 2023 Nov; 102(46):e35355. PubMed ID: 37986345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
    Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
    Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome.
    Elias MH; Baba AA; Azlan H; Rosline H; Sim GA; Padmini M; Fadilah SA; Ankathil R
    Leuk Res; 2014 Apr; 38(4):454-9. PubMed ID: 24456693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Diagnosis and Typological Characteristics Associated with Ferroptosis for Ulcerative Colitis
    Wang W; Song X; Ding S; Ma H
    Endocr Metab Immune Disord Drug Targets; 2024; 24(8):946-957. PubMed ID: 37957905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
    Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
    BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Ferroptosis-related potential biomarkers and immunocyte characteristics in Chronic Thromboembolic Pulmonary Hypertension via bioinformatics analysis.
    Lin J; Lin S; Zhang Y; Liu W
    BMC Cardiovasc Disord; 2023 Oct; 23(1):504. PubMed ID: 37821869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Single-Cell RNA-Seq reveals mechanism of Selinexor-Resistance in Chronic myeloid leukemia.
    Cui Y; Li Y; Ji J; Hu N; Min K; Ying W; Fan L; Hong M; Li J; Sun Z; Qu X
    Int Immunopharmacol; 2024 Jun; 134():112212. PubMed ID: 38728882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Analysis of Ferroptosis-Related Genes in Small Cell Lung Cancer for the Identification of Biomarkers and Therapeutic Targets.
    Yunchu Y; Miyanaga A; Seike M
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):125. PubMed ID: 37395033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Ferroptosis-Associated Gene Signatures as Diagnostic and Therapeutic Targets for Sepsis-Induced Cardiomyopathy.
    Huang H; Ge C; Dai Y; Wu Y; Zhu J
    Cureus; 2024 May; 16(5):e60439. PubMed ID: 38887322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML).
    Wu J; Wang A; Li X; Chen C; Qi Z; Hu C; Wang W; Wu H; Huang T; Zhao M; Wang W; Hu Z; Liu Q; Wang B; Wang L; Li L; Ge J; Ren T; Xia R; Liu J; Liu Q
    Cancer Biol Ther; 2019; 20(6):877-885. PubMed ID: 30894066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production.
    Ko BW; Han J; Heo JY; Jang Y; Kim SJ; Kim J; Lee MJ; Ryu MJ; Song IC; Jo YS; Kweon GR
    Leuk Lymphoma; 2016 Sep; 57(9):2180-8. PubMed ID: 26854822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.